| __timestamp | ADMA Biologics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 1802274 |
| Thursday, January 1, 2015 | 6745968 | 2512761 |
| Friday, January 1, 2016 | 8494742 | 2894488 |
| Sunday, January 1, 2017 | 18092835 | 8096274 |
| Monday, January 1, 2018 | 22502922 | 7985229 |
| Tuesday, January 1, 2019 | 25910757 | 8994597 |
| Wednesday, January 1, 2020 | 35050817 | 29772000 |
| Friday, January 1, 2021 | 42896889 | 33907000 |
| Saturday, January 1, 2022 | 52458024 | 26579000 |
| Sunday, January 1, 2023 | 59020000 | 49868547 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, understanding spending patterns is crucial. Over the past decade, from 2014 to 2023, Verona Pharma plc and ADMA Biologics, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. ADMA Biologics has seen a consistent rise, with expenses increasing by over 1,100% from 2014 to 2023. In contrast, Verona Pharma's SG&A expenses surged significantly in 2023, reaching nearly 50 million, marking a 2,700% increase since 2014. This divergence highlights ADMA's steady growth strategy, while Verona's recent spike suggests a strategic pivot or expansion. Such insights are invaluable for investors and industry analysts aiming to gauge company strategies and market positioning.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Halozyme Therapeutics, Inc. or ADMA Biologics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Selling, General, and Administrative Costs: Axsome Therapeutics, Inc. vs ADMA Biologics, Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Mesoblast Limited